GATC Biotech conducts research to detect cancer in women
As a partner of the research project EpiFemCare, GATC Biotech will manage sample processing, i.e. the DNA isolation from serum and the reduced representation bisulfite sequencing from serum derived DNA. This method analyses DNA methylation in normal and tumor DNA. 6 institutions from 5 European countries combining the best clinical, scientific and industrial expertise have joined forces to add a new dimension to the treatment of cancer in women. The € 5.8 Mio project from the European Commission will develop and test new methods for screening, diagnosing and personalising treatment of breast and ovarian cancer.
Most read news
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.